Fritextsökning
Innehållstyper
-
What will be the next big hype after obesity? – An expert panel highlighted their top picks
What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...
-
Kvinnan bakom Novo Nordisks fetmasuccé: ”Slutade aldrig tro på GLP-1”
Det tog flera år av misslyckanden inom GLP-1 innan Lotte Bjerre Knudsen och hennes kollegor hittade rätt – men då var det en riktig fullträff. "Vi investerade i...
-
Festo Expands its Portfolio with Multilayer Manifolds
Manufacturers of medical and laboratory equipment now receive solutions from a single source
-
Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”
It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...
-
Study: Vaccination linked to lower risk of post-COVID
The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.
-
Utvecklar snabb diagnostik vid sepsis – ”Varje timme räknas”
Rätt antibiotika i rätt dos – och det med en ultrasnabb analysmetod. Gradientechs produktlösning används idag i rutindiagnostik på flera sjukhus i Europa – och ...
-
Scale Up Your Image Analysis
ZEISS arivis Hub for accelerated analysis and faster results.
-
Viktigt steg för Neola – ska göra studie med för tidigt födda
Efter år av utvecklingsarbete av sitt lungövervakningssystem har Neola Medical fått ett glädjande besked: ett tillstånd att starta sin första kliniska studie på...
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
Digital Temperature Sensors from ZEISS
New Metrology Expert Tip video.
-
Compact and leak-tight powerhouse
Media-separated solenoid valve VYKA from Festo is virtually leak-free
-
CSL Behring: Nya terapier kräver nya betalningsmodeller
DEBATT: NT-rådets beslut att inte rekommendera en genterapi för hemofili på grund av kostnad och osäker effektlängd belyser vikten av att terapier mot sällsynta...
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
Artificial intelligence in radiology – “Risk prediction is very exciting”
A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...
-
Anna Törner: ”Mom, do you think you’ll ever get married again?”
”I realize I’m slowly descending into that familiar statistical rabbit hole, where life’s biggest uncertainties are reduced to point estimates and confidence in...
-
Bioscience – Groundbreaking Research & Diagnostics: Gothenburg 2026
-
Explore the latest trends and innovations in quality assurance and manufacturing
ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
The International Vaccine Institute’s office in Sweden is expanding
The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...
-
”Information security must become part of the Swedish life science strategy”
Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.
-
High biological age is linked to a higher risk of dementia and stroke
It is a well-known fact that people age at different rates, and a recent study at the Karolinska Institute suggests that people with a biological age higher tha...
-
Flerie och Toleranzia i fusion – ”Vi gör det andra bara talar om”
Styrelserna för investmentbolaget Flerie och biotechbolaget Toleranzia har enats om en fusionsplan för de två bolagen.
-
ZEISS Quality Innovation Days
The leading digital event from April 15-19, 2024.
-
Medical device quality assurance
Recordings from ZEISS Quality Innovation Days.